These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

151 related articles for article (PubMed ID: 38383947)

  • 21. Early identification of autism in fragile X syndrome: a review.
    McCary LM; Roberts JE
    J Intellect Disabil Res; 2013 Sep; 57(9):803-14. PubMed ID: 22974167
    [TBL] [Abstract][Full Text] [Related]  

  • 22. FORWARD: A Registry and Longitudinal Clinical Database to Study Fragile X Syndrome.
    Sherman SL; Kidd SA; Riley C; Berry-Kravis E; Andrews HF; Miller RM; Lincoln S; Swanson M; Kaufmann WE; Brown WT
    Pediatrics; 2017 Jun; 139(Suppl 3):S183-S193. PubMed ID: 28814539
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Fragile X Syndrome: Supportive Treatment, Unmet Needs, and Paths to Novel Interventions and Disease-Targeted Therapies.
    Berry-Kravis E
    Am J Intellect Dev Disabil; 2022 Mar; 127(2):90-94. PubMed ID: 35180774
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Melatonin as a Novel Interventional Candidate for Fragile X Syndrome with Autism Spectrum Disorder in Humans.
    Won J; Jin Y; Choi J; Park S; Lee TH; Lee SR; Chang KT; Hong Y
    Int J Mol Sci; 2017 Jun; 18(6):. PubMed ID: 28632163
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Diagnostic, carrier and prenatal genetic testing for fragile X syndrome and other FMR-1-related disorders in Johannesburg, South Africa: a 20-year review.
    Essop FB; Krause A
    S Afr Med J; 2013 Oct; 103(12 Suppl 1):994-8. PubMed ID: 24300646
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Fragile X syndrome and FMR1-dependent diseases - clinical presentation, epidemiology and molecular background].
    Landowska A; Rzońca S; Bal J; Gos M
    Dev Period Med; 2018; 22(1):14-21. PubMed ID: 29641417
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Advancing artificial intelligence-assisted pre-screening for fragile X syndrome.
    Movaghar A; Page D; Brilliant M; Mailick M
    BMC Med Inform Decis Mak; 2022 Jun; 22(1):152. PubMed ID: 35689224
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Cerebellum neuropathology and motor skill deficits in fragile X syndrome.
    Chen YS; Guo L; Han M; Zhang SM; Chen YQ; Zou J; Bai SY; Cheng GR; Zeng Y
    Int J Dev Neurosci; 2022 Nov; 82(7):557-568. PubMed ID: 35870148
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Exploring Parents' Concerns Regarding Long-Term Support and Living Arrangements for Their Children with Fragile X Syndrome.
    Shuleski K; Zalles L; Lozano R
    Genes (Basel); 2022 Sep; 13(9):. PubMed ID: 36140821
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Fragile X Premutation Carrier Epidemiology and Symptomatology in Israel-Results from a Tertiary Child Developmental Center.
    Gabis LV; Gruber N; Berkenstadt M; Shefer S; Attia OL; Mula D; Cohen Y; Elizur SE
    Cerebellum; 2016 Oct; 15(5):595-8. PubMed ID: 27312842
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Behavior Problems and Social Competence in Fragile X Syndrome: A Systematic Review.
    Cregenzán-Royo O; Brun-Gasca C; Fornieles-Deu A
    Genes (Basel); 2022 Jan; 13(2):. PubMed ID: 35205326
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Autism Spectrum Disorder in Fragile X Syndrome: Cooccurring Conditions and Current Treatment.
    Kaufmann WE; Kidd SA; Andrews HF; Budimirovic DB; Esler A; Haas-Givler B; Stackhouse T; Riley C; Peacock G; Sherman SL; Brown WT; Berry-Kravis E
    Pediatrics; 2017 Jun; 139(Suppl 3):S194-S206. PubMed ID: 28814540
    [TBL] [Abstract][Full Text] [Related]  

  • 33. FMR1 gene and fragile X syndrome.
    Bardoni B; Mandel JL; Fisch GS
    Am J Med Genet; 2000; 97(2):153-63. PubMed ID: 11180223
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Fragile X syndrome: new therapeutic strategies].
    Zeidler S; Dierckx B; Lubbers K; van Eeghen AM; Lincke CR; Kievit JA; Willemsen R; Rietman A
    Tijdschr Psychiatr; 2018; 60(5):338-342. PubMed ID: 29766482
    [TBL] [Abstract][Full Text] [Related]  

  • 35. An effective strategy of using molecular testing to screen mentally retarded individuals for fragile X syndrome.
    Tzeng CC; Lin SJ; Chen YJ; Kuo PL; Jong YJ; Tsai LP; Chen RM
    Diagn Mol Pathol; 2001 Mar; 10(1):34-40. PubMed ID: 11277393
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Pediatricians' knowledge of and attitudes toward fragile X syndrome screening.
    Kemper AR; Bailey DB
    Acad Pediatr; 2009; 9(2):114-7. PubMed ID: 19329102
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Fragile X syndrome: A review of clinical management.
    Lozano R; Azarang A; Wilaisakditipakorn T; Hagerman RJ
    Intractable Rare Dis Res; 2016 Aug; 5(3):145-57. PubMed ID: 27672537
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Fragile X syndrome.
    Saldarriaga W; Tassone F; González-Teshima LY; Forero-Forero JV; Ayala-Zapata S; Hagerman R
    Colomb Med (Cali); 2014; 45(4):190-8. PubMed ID: 25767309
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Establishment of FXS-A9 panel with a single human X chromosome from fragile X syndrome-associated individual.
    Nakayama Y; Adachi K; Shioda N; Maeta S; Nanba E; Kugoh H
    Exp Cell Res; 2021 Jan; 398(2):112419. PubMed ID: 33296661
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Inequities in diagnosis of Fragile X syndrome in Colombia.
    Saldarriaga-Gil W; Cabal-Herrera AM; Fandiño-Losada A; Vásquez A; Hagerman R; Tassone F
    J Appl Res Intellect Disabil; 2021 May; 34(3):830-839. PubMed ID: 33538083
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.